Price data is not available
Comments
Loading...
Rapport sur les intérêts à découvert
L'intérêt à découvert sur Perspective Therapeutics Inc (AMEX:CATX) a diminué lors de la dernière période de déclaration, augmentant de en baisse de 6.78M à 6.49M. Cela représente 12.38% des actions disponibles au public de l'entreprise.
Sur la base du volume moyen récent de 1.37M actions échangées par jour, il faudrait 4.73 jour(s) aux détenteurs de cet intérêt à découvert pour clôturer leurs positions sans faire monter brusquement le cours de l'action.
Intérêt à court terme
6.49M
Intérêt à court terme %
12.4%
Jours de couverture
4.73
Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|
CATX | Perspective Therapeutics, Inc. | 10/15/2025 | 10/24/2025 | 12.38% | 52,456,457 | 6,492,938 | 1,371,994 | 4.73 | |
CATX | Perspective Therapeutics, Inc. | 09/30/2025 | 10/09/2025 | 12.92% | 52,456,457 | 6,776,377 | 822,278 | 8.24 | |
CATX | Perspective Therapeutics, Inc. | 09/15/2025 | 09/24/2025 | 12.72% | 52,456,457 | 6,671,693 | 817,331 | 8.16 | |
CATX | Perspective Therapeutics, Inc. | 08/29/2025 | 09/10/2025 | 12.15% | 52,456,457 | 6,373,501 | 598,669 | 10.65 | |
CATX | Perspective Therapeutics, Inc. | 08/15/2025 | 08/26/2025 | 11.98% | 52,456,457 | 6,285,168 | 670,362 | 9.38 | |
CATX | Perspective Therapeutics, Inc. | 07/31/2025 | 08/11/2025 | 12.39% | 52,421,801 | 6,496,317 | 769,260 | 8.44 | |
CATX | Perspective Therapeutics, Inc. | 07/15/2025 | 07/24/2025 | 12.11% | 52,421,801 | 6,347,204 | 1,179,926 | 5.38 | |
CATX | Perspective Therapeutics, Inc. | 06/30/2025 | 07/10/2025 | 11.91% | 52,421,801 | 6,242,706 | 1,662,123 | 3.76 | |
CATX | Perspective Therapeutics, Inc. | 06/13/2025 | 06/25/2025 | 10.71% | 52,421,801 | 5,616,516 | 2,077,510 | 2.7 | |
CATX | Perspective Therapeutics, Inc. | 05/30/2025 | 06/10/2025 | 10.07% | 52,421,801 | 5,278,241 | 884,200 | 5.97 | |
CATX | Perspective Therapeutics, Inc. | 05/15/2025 | 05/27/2025 | 10.79% | 52,421,801 | 5,654,023 | 590,376 | 9.58 | |
CATX | Perspective Therapeutics, Inc. | 04/30/2025 | 05/09/2025 | 10.08% | 52,244,308 | 5,266,566 | 688,368 | 7.65 | |
CATX | Perspective Therapeutics, Inc. | 04/15/2025 | 04/25/2025 | 9.61% | 52,244,308 | 5,022,843 | 1,161,618 | 4.32 | |
CATX | Perspective Therapeutics, Inc. | 03/31/2025 | 04/09/2025 | 9.21% | 61,998,104 | 5,710,412 | 639,697 | 8.93 | |
CATX | Perspective Therapeutics, Inc. | 03/14/2025 | 03/25/2025 | 10.70% | 55,533,803 | 5,939,698 | 518,201 | 11.46 | |
CATX | Perspective Therapeutics, Inc. | 02/28/2025 | 03/11/2025 | 10.64% | 55,533,803 | 5,909,500 | 644,244 | 9.17 | |
CATX | Perspective Therapeutics, Inc. | 02/14/2025 | 02/26/2025 | 9.87% | 55,533,803 | 5,480,817 | 553,735 | 9.9 | |
CATX | Perspective Therapeutics, Inc. | 01/31/2025 | 02/11/2025 | 9.76% | 55,533,803 | 5,417,505 | 1,088,511 | 4.98 | |
CATX | Perspective Therapeutics, Inc. | 01/15/2025 | 01/27/2025 | 13.75% | 55,533,803 | 7,633,209 | 1,197,831 | 6.37 | |
CATX | Perspective Therapeutics, Inc. | 12/31/2024 | 01/10/2025 | 16.08% | 55,533,803 | 8,931,987 | 1,297,306 | 6.89 | |
CATX | Perspective Therapeutics, Inc. | 12/13/2024 | 12/24/2024 | 17.85% | 55,533,803 | 9,912,952 | 1,444,394 | 6.86 | |
CATX | Perspective Therapeutics, Inc. | 11/29/2024 | 12/10/2024 | 18.81% | 55,533,803 | 10,445,797 | 4,413,970 | 2.37 | |
CATX | Perspective Therapeutics, Inc. | 11/15/2024 | 11/26/2024 | 14.90% | 55,533,803 | 8,277,033 | 907,121 | 9.12 | |
CATX | Perspective Therapeutics, Inc. | 10/31/2024 | 11/11/2024 | 14.49% | 55,373,930 | 8,022,108 | 598,624 | 13.4 | |
CATX | Perspective Therapeutics, Inc. | 10/15/2024 | 10/24/2024 | 14.23% | 55,373,930 | 7,881,299 | 1,178,000 | 6.69 | |
CATX | Perspective Therapeutics, Inc. | 09/30/2024 | 10/09/2024 | 17.32% | 55,373,930 | 9,589,415 | 1,286,675 | 7.45 | |
CATX | Perspective Therapeutics, Inc. | 09/13/2024 | 09/24/2024 | 12.90% | 55,373,930 | 7,141,541 | 817,551 | 8.74 | |
CATX | Perspective Therapeutics, Inc. | 08/30/2024 | 09/11/2024 | 11.60% | 55,373,930 | 6,422,919 | 708,983 | 9.06 | |
CATX | Perspective Therapeutics, Inc. | 08/15/2024 | 08/26/2024 | 12.55% | 55,373,930 | 6,951,430 | 572,854 | 12.13 | |
CATX | Perspective Therapeutics, Inc. | 07/31/2024 | 08/09/2024 | 12.25% | 55,360,754 | 6,782,317 | 624,628 | 10.86 | |
CATX | Perspective Therapeutics, Inc. | 07/15/2024 | 07/24/2024 | 11.98% | 55,360,754 | 6,633,966 | 857,396 | 7.74 | |
CATX | Perspective Therapeutics, Inc. | 06/28/2024 | 07/10/2024 | 7.78% | 55,360,754 | 4,306,555 | 2,047,392 | 2.1 | |
CATX | Perspective Therapeutics, Inc. | 06/14/2024 | 06/26/2024 | 53.88% | 55,360,754 | 29,826,776 | 6,916,174 | 4.31 | |
CATX | Perspective Therapeutics, Inc. | 05/31/2024 | 06/11/2024 | 4.23% | 553,607,549 | 23,435,459 | 7,390,953 | 3.17 | |
CATX | Perspective Therapeutics, Inc. | 05/15/2024 | 05/24/2024 | 3.04% | 502,091,669 | 15,259,104 | 6,262,659 | 2.44 | |
CATX | Perspective Therapeutics, Inc. | 04/30/2024 | 05/09/2024 | 2.91% | 466,378,608 | 13,594,041 | 4,785,758 | 2.84 | |
CATX | Perspective Therapeutics, Inc. | 04/15/2024 | 04/24/2024 | 2.24% | 466,378,608 | 10,432,695 | 7,970,727 | 1.31 | |
CATX | Perspective Therapeutics, Inc. | 03/28/2024 | 04/09/2024 | 1.74% | 466,378,608 | 8,092,736 | 3,712,028 | 2.18 | |
CATX | Perspective Therapeutics, Inc. | 03/15/2024 | 03/26/2024 | 0.32% | 584,680,051 | 1,880,666 | 4,428,801 | 1 | |
CATX | Perspective Therapeutics, Inc. | 02/29/2024 | 03/11/2024 | 0.32% | 584,565,051 | 1,872,350 | 1,409,623 | 1.33 | |
CATX | Perspective Therapeutics, Inc. | 02/15/2024 | 02/27/2024 | 0.61% | 492,358,673 | 3,005,886 | 2,755,405 | 1.09 | |
CATX | Perspective Therapeutics, Inc. | 01/31/2024 | 02/09/2024 | 0.42% | 492,358,673 | 2,053,847 | 2,762,832 | 1 | |
CATX | Perspective Therapeutics, Inc. | 01/12/2024 | 01/24/2024 | 0.39% | 492,358,673 | 1,934,411 | 2,534,752 | 1 | |
CATX | Perspective Therapeutics, Inc. | 12/29/2023 | 01/10/2024 | 0.69% | 278,335,100 | 1,932,877 | 1,472,166 | 1.31 | |
CATX | Perspective Therapeutics, Inc. | 12/15/2023 | 12/27/2023 | 0.65% | 278,335,100 | 1,808,113 | 373,541 | 4.84 | |
CATX | Perspective Therapeutics, Inc. | 11/30/2023 | 12/11/2023 | 0.66% | 278,335,100 | 1,840,409 | 242,327 | 7.59 | |
CATX | Perspective Therapeutics, Inc. | 11/15/2023 | 11/27/2023 | 0.69% | 278,335,100 | 1,932,984 | 314,813 | 6.14 |
À la recherche des actions les plus vendues à découvert?